HeartBeam, Inc. (NASDAQ: BEAT), a company dedicated to revolutionizing cardiac care, has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its HeartBeam system for…
Reprieve Cardiovascular, Inc., a company focused on developing treatments for acute decompensated heart failure (ADHF), announced today the first-in-human results of the Reprieve System at the CSI Focus D-HF (Device…
HistoSonics, the maker of the Edison® Histotripsy System, announced the successful treatment of the first pancreatic tumor patients in its GANNON trial. This feasibility study aims to assess the safety…
NeoPhore Limited, a company specializing in small molecule neoantigen immuno-oncology therapies, has appointed Michael Shih as its Chief Executive Officer (CEO) and as a member of the Board of Directors,…
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC), a clinical-stage biotherapeutics company, today announced positive results from the Phase 2b ELEVATE IPF trial. The study evaluated deupirfenidone (LYT-100) in patients with…
NextGen Healthcare has been selected by the Fairfax-Falls Church Community Services Board (CSB) to enhance its healthcare services for residents in Fairfax County, Virginia, and neighboring cities. The CSB, dedicated…
Gilead Sciences, Inc. (Nasdaq: GILD) recently announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion for the approval of seladelpar…
Klick Health has announced the Grand Prize winner of the $1,000,000 Klick Prize, following the submission of several hundred AI ideas from employees for life sciences clients. The company shared…
Upbound Group, Inc. (NASDAQ: UPBD), a leader in accessible and inclusive financial products powered by technology and data, has announced a definitive agreement to acquire Brigit, a top financial health…
Lyra Health, a leader in Workforce Mental Health solutions for employers, today shared early insights from its 2025 Workforce Mental Health Trends Forecast. The fifth annual study found that 81%…
Alpha Cognition Inc. (Nasdaq: ACOG) (CSE: ACOG), a biopharmaceutical company focused on developing innovative therapies for neurodegenerative disorders, today announced promising interim preclinical data supporting the ongoing development of ALPHA-1062…
SurgeonCheck has launched an innovative surgeon recommendation tool. By visiting www.surgeoncheck.com, patients can easily find personalized suggestions for top surgeons in their area, powered by an extensive analysis of clinical…